The cestrogens form one group of carcinogenic agents, but I wish to speak about other groups. There are a number of nitrogenous carcinogenic agents such as azo dyes like butter yellow, certain basic stilbene derivatives such as 4-dimethylaminostilbene, polycyclic amines like 2-acetylaminofluorene, and heterocyclic compounds like 3:4:5:6-dibenzcarbazole. These nitrogenous carcinogens have the power of inducing cancer at sites remote from the original point of application of the drug. The fundamental mechanism of these compounds, however, is probably similar to that of the carcinogenic hydrocarbons, which have primarily a local action.
Carcinogenic hydrocarbons The discovery of the first carcinogenic hydrocarbons by Sir Ernest Kennaway and his colleagues showed that important biological changes such as the conversion of normal into malignant cells were brought about by what appeared to be rather inert substances, which were insoluble in water. The chemical inertness and insolubility in water suggested that the substances might act in the lipoid phase of cells or were converted into biologically active derivatives as the water insoluble carotene is converted into the active vitamin A protein complexes such as visual purple in the body. Alternatively they may be absorbed to some essential cell constituent. The problem of the reactivity of carcinogenic hydrocarbons has completely changed since the early thirties when the chemical inactivity of the substances seemed remarkable. Now, on the contrary, so many reactions are known that the difficulty is to decide which, if indeed any, are of biological importance. Professor Cook showed that the carcinogenic hydrocarbons could be oxidised to quinones by vigorous oxidising agents, but such quinones are not carinogenic (Barry et al.1) . The introduction of polar groups, such as phenolic hydroxyl groups or carboxyl groups, invariably leads to the destruction of the carcinogenic activity. Less polar groups such as methoxyl groups do not destroy the ability to produce tumours, and non-polar substituents such as methyl may enhance carcinogenic power if they occupy the right positions.
Many carcinogenic compounds are fluorescent and it is not possible to say how fluorescence is related to carcinogenic power, but changes in the molecule which reduce the fluorescence, destroy the carcinogenic activity. As is well known, the hypothesis that fluorescence of tar constituents is associated with carcinogenicity was extremely valuable, and the use of this physical property as a clue led to the isolation of benzpyrene from pitch and to the synthesis of active derivatives of 1: 2-benzanthracene. Although fluorescence may be an important factor in carcinogenesis, some carcinogenic agents other than hydrocarbons are not fluorescent. Fluorescent substances are step-down transformers of radiant energy and it is possible that the agents act by converting some kind of radiant energy within the tissues into energy forms which are carcinogenic in the way that radiations such as X-rays are carcinogenic. An alternative hypothesis that carcinogenic compounds and also radiations produce some common condition leading to the induction of tumours seems a more plausible explanation for the similarity in action of the two groups of agents.
The carcinogenic hydrocarbons and the carcinogenic compounds containing nitrogen or sulphur such as the carbazole, acridine, and thiophanthrene derivatives are all flat planar molecules. Modifications of the structure which change the planar nature lead to loss of activity.
The carcinogenic trans aminostilbenes (Haddow and The main known metabolic path of hydrocarbons and nitrogenous carcinogens is hydroxylation. In the metabolism of naphthalene, 3, 25 anthracene,6 and phenanthrene, the products have been shown to be diols or dihydroxy dihydro derivatives. This metabolic process has been called perhydroxylation because it involves the addition of the atoms of hydrogen peroxide to the molecule. The aromatic character of the ring to which the hydroxyl groups are added is destroyed as a result of the addition to the double bond. All these diols are unstable in acid solution, when they lose water to be converted into phenols which are again aromatic in character. The phenolic metabolites which have been isolated after dosing animals with hydrocarbons or with other aromatic compounds are probably artefacts or decomposition products arising from further change of the diols. In the cases of carcinogenic compounds, only phenolic metabolites have so far been actually isolated and definitely characterised. The first of these phenols to be isolated were the dihydroxyphenols produced from 1:2:5:6-dibenzanthracene. Dobriner, Rhoads, and Lavin13 isolated a phenol from the urine of rats and mice injected with 1:2:5: 6-dibenzanthracene which was identical with 4':8'-dihydroxy-1:2:5:6-dibenzanthracene synthesised by Cason positions of tertiary activity is also shown by the production of 4'-hydroxy-1 : 2-benzanthracene from 1: 2-benzanthracene and of 4'-hydroxy-9:10-dimethyl-1:2-benzanthracene from the highly carcinogenic 9: 10-dimethyl-1: 2-benzanthracene by rats. The 3:4-benzpyrene molecule is more complicated and the metabolism more difficult to interpret on the basis of reactivity, since a mixture of 8 and 10 benzpyrenols is excreted by both rats and rabbits treated with 3:4-benzpyrene (Berenblum et al.2) . But in neither of the products has the hydroxyl group entered the most reactive 5 position, the K region, or the phenanthrene bridge position.
Such of these phenolic metabolism products as have been tested are themselves non-carcinogenic but the methylated benzpyrenols or methoxy benzpyrene derivatives are carcinogenic. These non-carcinogenic phenols are probably products formed from non-phenolic diols. Weigert26 studied benzpyrene metabolism in mice and, although most of the products were not actually isolated, they were identified or characterised by means of chemical properties and absorption spectra and fluorescent spectra of minute amounts of material. When benzpyrene is injected into intact mice or painted on the detached skin of mice, it is first converted into a product with a blue fluorescence different from that of benzpyrene itself. Such a derivative was first described by Pea The data would fit in with the idea that BPX1 is a diol and BPX2 its glycuronide. It was suggested that BPX2 was possibly formed under conditions in which tumour production was slow and therefore could be considered as a detoxication process, but the known facts are insufficient to determine whether this is the case or not.
That the blue fluorescing BPX is a diol is probable because of the following facts. First, the compound BPX is easily converted by acid hydrolysis to the phenolic benzpyrenol, in the same way that the naphthalene diol is converted to the corresponding naphthol. Second, the ultraviolet absorption of BPX shows much less fine structure and is mainly at shorter wave-lengths than that of the corresponding known benzpyrenol. The first trough of the absorption is 150 A farther into the ultraviolet than that of the corresponding phenol. The absorption of the naphthalene diol shows analogous differences from that of naphthol. Third, BPX is soluble in water but the fluorescence is unchanged by acid and alkali so that the hydroxyl groups have no phenolic properties. The fluorescence of BPF or benzpyrenol is changed by alkali because of the phenolic nature of the hydroxyl group.
We are therefore probably justified in considering this relation of the metabolic products of benzpyrene as a reasonable hypothesis. It is, however, possible that metabolism of carcinogens by perhydroxylation is a detoxication and is not directly associated with the carcinogenic change, but I think the change is essential for carcinogenesis, and the dihydroxy dihydro derivative or the energy changes concerned with its formation or breakdown are the proximate causes of carcinogenesis and I will try to summarise the experimental evidence on the subject.
The conversion of carcinogens to water-soluble diols occurs in mouse skin. If Another argument in favour of the hypothesis I wish to put forward depends upon the relation of the stereo isomers of the diols produced by different species and the difference in response to carcinogens.
If a cold solution of 1:2:5:6-dibenzanthracene is injected into mice or rats it induces tumours in most cases at the site of injection, but the same material injected into rabbits does not produce tumours at the site of injection. Some other carcinogens will produce local tumours in rabbits, but rabbits are undoubtedly more resistant to carcinogens than are rats or mice. Now when naphthalene and anthracene are injected into rats and rabbits they are metabolished to diols which contain two asymmetric carbon atoms. The spacial configurations of the diols produced are different in the two species. In the case of naphthalene, the rat product is lavo-rotatory and the rabbit product is dextro-rotatory.' Chemical examination of the compounds, and particularly their reaction rate with lead tetra-acetate, indicates that the hydroxyl groups in both compounds have the trans configuration.8 The rat and rabbit products appear to be optical antipodes or mirror images of the same compound. The products from anthracene which I have investigated with Dr. Levi' and Dr. Shoppee,8 and phenanthrene, which has been studied by Dr. Wolf and myself, are not so simple, but the metabolic products of the species showing differences in optical activity have been isolated. Extension of these results to carcinogens would suggest that rabbits convert a carcinogenic hydrocarbon into a diol with a dextro configuration which is not carcinogenic, while rats and mice convert the hydrocarbons into derivatives of the lavo series which are carcinogenic.
An analogous species difference in carcinogenicity and metabolism is found with ,B-naphthylamine. When given to dogs 3-naphthylamine is excreted as the sulphate of 2-amino-1-naphthol, and f-naphthylamine induces cancer of the bladder in dogs. In other species, including rats and rabbits, no bladder tumours are induced and the excretion product is 2-acetylamino-6-hydroxy-naphthalene.
The formation of a diol involves the conversion of an aromatic ring into a non-aromatic or less unsaturated ring. The fact that the hydroxyl groups enter in positions other than those of the active K region indicates that the K region is probably combined with some tissue constituent. Now the combination through the K region may be due to substitution, in which case the ring containing the K region or phenanthrene double bond would remain aromatic. The bond of the K region, however, has ethylenic character which would favour addition rather than substitution. Also, there are the examples of two carcinogens 4:9-dimethyl-1 :2-benzanthracene and 4: 10-dimethyl-1 :2-benzanthracene in both of which one hydrogen of the K region is substituted by a methyl group. In such a compound, substitution could only occur in one of the positions. The known examples of reactivity of the K region are of addition reactions such as the catalytic hydrogenation and the perhydroxylation by osmic acid.
Whatever the combination on the atoms of the K region, it appears to be of a labile nature as only the free diol has been isolated and not the complexes. One possibility is that the partial saturation of the ring adjoining the K region changes the affinity of the bond so that the free diol is released. Although a highly active K region is Carcinogenesis and inhibition of growth Whatever the biochemical mechanism, it seems probable that one stage is due to growth inhibitory action of the carcinogen. Haddow has shown that carcinogens inhibit body growth and has described how the study of this inhibitory power led to the discovery of a new class of carcinogens, the aminostilbene derivatives. The aminostilbenes are remarkable growth-inhibitory compounds and produce tumours in a wide variety of tissues. Another carcinogen which biochemists would consider as a general inhibitor rather than as a stimulator is urethane. Urethane inhibits many enzymes, stops cell division in a way similar to radiations and the chloroethylamine drugs, and induces cancer of the lung in rats and mice. These facts do indeed suggest that the carcinogenic process involves an inhibitory stage and it may be in an effort to overcome such inhibition that the tumour cell arises. The type of structure suggested is presumably that responsible for the inhibition. Inhibitory processes of this kind seem to be associated with genetic instability. Urethane and the chloroethylamines like radiations, inhibit growth and also increase the incidence of mutations in Drosophila and other species, and Strong24 has shown that carcinogens increase the rate of genetic changes in mice. The linkage between the two phenomena of growth inhibition and genetic instability suggests that the underlying mechanism may involve the same cell constituents. The genetically stable form of cells may require a dynamic equilibrium with the momentum of growth and division conferring stability. With inhibition the chance of production of tumours or mutations is increased. The prolonged presence of the carcinogenic complex may increase the difficulties of cell division so that the risk of the accident of a somatic mutation occurring at cell division is increased. A proportion of these mutations may give rise to tumours.
The carcinogenic aminostilbenes The aminostilbenes which have been investigated by Haddow, Kon, and their colleagues'7 are particularly interesting from the point of view of carcinogenesis and inhibition as their inhibitory properties were discovered first. Having been shown to be effective inhibitors of growth, they were tested for carcinogenic action and were found to produce tumours in many parts of the body in a way similar to the action of 2-acetylaminofluorene.
The simplest compound of this group is p-aminostilbene which itself is rather toxic, producing methaemoglobinemia. Substitution of the amino group as in dimethylaminostilbene gave a compound of lower toxicity which was about ten times as effective as carcinogenic hydrocarbons in inhibiting the growth of grafted tumours in rats and mice. The activity was further enhanced by introduction of a methyl group or a chlorine group in the 2' position. If such substituents or a hydroxyl group were placed in the para or 4' position activity was lost. This effect is remarkable in that metabolic tudies indicate that 4-dimethylaminostilbene appears to be converted in the body to 4-amino-4'-hydroxystilbene.
The 2'-methyl and 2'chloro-4-dimethyl-aminostilbenes have been used in a few clinical trials on cancer patients. The problems of administration have not yet been entirely overcome and results comparable with those obtained by treatment of cancer of the prostate with cestrogens are still to be obtained. Recently Elson has found that the aminostilbenes and carcinogenic hydrocarbons are much more effective in inhibiting growth when given to animals maintained on a low protein diet than when given to those on a normal or high protein diet.
Urethane
Another carcinogen which has been used in therapy of malignant disease is urethane or ethyl carbamate. This simple and rather ineffective narcotic is able to induce cancer of the lung in rats and mice and is an inhibitor of cell division and mitosis. Although the effect of urethane on growing transplanted tumours is not very great, the drug has considerable effect in leukxmia and has been used with success as an alternative to radiation in treatment of cases of both lymphatic and myeloid leukoemia." Patients are given 3 or 4 gm. ethyl carbamate per day and at this level the drug does not appear to have even a soporific action. Urethane inhibits cell division in the early stages and causes "chromosome breaks" in the same way as do radiations. It therefore belongs to the class of radiomimetic poisons.
Chloroethylamines
Other drugs of this class of radiomimetic mitotic poisons are the nitrogen mustards or chloroethylamines of which methyl-bis-(13-chloroethyl)-amine, with code number HN2, is the best known example. Up to the present these compounds have not been shown to be carcinogenic, but I shall not be surprised if they are eventually found to be so. During the war the pharmacology of the nitrogen mustards or chlorethylamines was studied and their leukopenic action was demonstrated.
I admired the courage of the American workers"5 who first injected substances of this type into human patients. There is no doubt that the procedtire was justified and hundreds of patients suffering from Hodgkin's disease must by now have benefited by treatment with these drugs.
Our Repeated injection of animals did not seem to make them ill, although we have not looked for blood changes.
A curious side effect noticed in the injected mice was that the hair was bleached at the site of injection. It appeared that subcutaneous injection of the material caused a local inhibition of pigment formation without having any effect on the growth of hair. This effect is similar to that produced by radioactive material injected subcutaneously. We As animal experiments have shown that large single doses are more effective than are divided doses, and because the total amount of discomfort to the patient is decreased, by giving fewer but larger doses, we have given two injections of methyl-bis-(t-chloroethyl) amine (0.2 mg. per kg.) on consecutive days, and recently we have given single doses of 0.4 mg. per kg. In those cases in which a remission was noted, the treatment was repeated as soon as possible after symptoms recurred. Over half of the patients have had relief from their most distressing symptom. The effect on pain is remarkable in the majority of cases, relief being experienced within 8 to 48 hours. The deep-seated protopathic type of pain referred to as "being deep in the chest," is the type most commonly relieved in contrast to the more localised pleural type. Following treatment, cough is often decreased in severity and after an initial period of several days when the sputum increases and is said to "come up more easily," the amount may fall off rapidly in some cases from 90 to 120 ml. to 15 ml. or nil. The sputum frequently changes in character from purulent to colourless.
Although clinical remission of symptoms and observable beneficial effects may be noted in over half the cases of bronchogenic carcinoma treated, the remissions are only of short duration and the progression of the disease does not seem to be altered materially. Only two of our cases can be said to have had their life prolonged as a result of treatment. The marked relief of symptoms observed in many patients has justified the clinical use of the drug and further investigations are under way using larger doses and combining the drug with radiation therapy.
Aromatic amines in therapy
Early experiments on chemotherapy of cancer used the classical method of testing dyes for their ability to stain tumour tissue when injected intravenously, and revealed no dyes superior to trypan blue or isamine blue as vital stains for tumours. In general, acid dyes with aminonaphthol sulphonic acid residues acted as vital stains. Prontosil soluble, the forerunner of the sulphonamides, was first described about the time that the experiments were in progress. As prontosil contained an aminonaphthol sulphonic acid residue, it was likely to stain tumour tissue. When tested it acted as a tumour stain and on repeated injection reduced the rate of growth of tumours in mice. 4 Following this observation a number of sulphonamide derivatives were tested. Some of these had growth-inhibitory action when given repeatedly in large doses; the most effective was 4:4'-diaminodiphenylsulphoxide. The next step was to test a number of diaminodiphenyl compounds, and it was soon seen that the sulphur atom was not essential for activity. The best compound of this series was 4:4'-diaminodiphenylether and we have been unable to improve on this compound in this series.' Diaminodiphenylether shows some specificity in that it inhibits the growth of spontaneous mammary tumours in mice, but has no effect on grafted sarcomata or on a transplanted lymphosarcoma. This Hemorrhagic agents One class of substances which has been investigated includes those which produce a hemorrhagic reaction in tumours. These belong mainly to two types-the bacterial products which elicit the Shwartzman phenomenon, and colchicine and related substances. These agents are more toxic to tumour-bearing animals than to normal animals, and they produce more effect in grafted tumours than in spontaneous or induced tumours. The effect is associated with a pyrogen, and animal and human tumours become resistant to later treatment.
Colchicine induces hemorrhage in tumours in addition to inhibiting mitosis in metaphase. Colchicine is rather toxic for use in therapy, but if a compound with a similar action on tumour tissue and with less action on the alimentary tract were found, it should be of value. Recently much work, has been carried out with podophyllin which seems to have some of the effects of colchicine.
Methods of testing
The usual line of progress in biochemical research is first to find some biological property which can be affected by a preparation and then to develop methods of biological assay which will give quantitative data on biological effectiveness. In chemotherapy of cancer the methods of assay, or what are called "screening tests," are still inadequate. There is reason to expect remedies for cancer of particular sites rather than for cancer in general. A drug with a specific action on a particular type of tumour is less likely to damage other normal tissues, so that the limitation of action may be a good thing. For this reason, potential therapeutic agents for cancer should be tested against as wide a range of tumours as possible. Difficulties arise in the establishment of suitable animal tumours particularly with animals of pure lines, and such animals are of the greatest value for this work. We hope to have established a series of tumours in mice including a mammary carcinoma, a sarcoma, a hepatoma, a prostatic carcinoma, a lung tumour, a lymphosarcoma, a leukoemia, and a gastric carcinoma. In addition to such tumours, wellestablished transplanted tumours such as the Walker rat carcinoma are of great value.
The methods used may depend upon measurement of growth or of duration of life, or alternatively in histological, hxmatological, and cytological changes caused by treatment. The increase in length of life is the most practical criterion to use, but in the case of animals with spontaneous tumours, the expected survival time of untreated animals is very variable and difficult to assess. In such cases the growth rate of the tumour is taken into consideration with the body weight and general health of the animal. With transplanted tumours, the extension of life by treatment seems to be the most satisfactory guide, but in all cases, histology and cytology can help in indicating the possible mechanism of drug action.
There is little doubt that in the problem of cancer therapy we have established the fact that some therapeutic effect against cancer can be shown, so that some standards are established-the next steps should be to establish methods of testing, using quantitative methods, and to determine the mode of action of such agents as we have available for the control of cancer growth. If good methods for assay of chemotherapeutic effectiveness can be established, then progress to rational chemotherapy of cancer should be assured.
